Sevelamer Hydrochloride
Product Images NDC 0955-5902

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 0955-5902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Chemical Structure)

Chemical structure diagram displaying the polymer composition of Sevelamer Hydrochloride. The structure shows repeating polymer units with amino groups complexed with hydrochloride ions and hydroxyl groups, illustrating the chemical makeup of the active ingredient.*

FDA Label Image

Figure 2 (Sevelamerhcl 02)

A line graph comparing the effect of Sevelamer Hydrochloride versus an active control on the reduction of serum phosphorus levels in patients. The x-axis shows reduction in serum phosphorus (mg/dL) ranging roughly from -4 to 8, and the y-axis indicates the percentage of patients achieving that reduction, from 0 to 100%. The graph shows two lines representing Sevelamer Hydrochloride and Active Control, illustrating the distribution of patients' responses in terms of improved reduction or worsened increase from baseline serum phosphorus levels.*

FDA Label Image

Figure 3 (Sevelamerhcl 03)

A line graph showing phosphorus change from baseline over 52 study weeks comparing Sevelamer Hydrochloride and an active control. The phosphorus levels decrease initially and remain relatively stable over time for both treatment groups, with Sevelamer Hydrochloride indicated by solid black circles and active control by red open squares.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Label for Sevelamer Hydrochloride Tablets 800 mg, manufactured by Sanofi-Aventis U.S. LLC under the Winthrop brand. The label indicates 180 tablets per container and includes active ingredient and inactive ingredients. Storage instructions and dosage information references are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.